Korro BioKRRO -12.05%6 EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus rates KRRO with a GF Score™ of 6/100. The stock has 4 warning signs investors should review. Among 945 Biotechnology companies, Korro Bio ranks worse than 84.76% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Korro Bio's EBITDA for the
three
months ended in Mar. 2026 was $-20.06 Mil. Korro Bio's Revenue for the
three
months ended in Mar. 2026 was $0.00 Mil. Therefore, Korro Bio's EBITDA margin for the quarter that ended in Mar. 2026 was 0.00%.
Korro Bio (NAS:KRRO) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Korro Bio EBITDA Margin % Related Terms
Korro Bio EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Korro Bio's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KRRO vs TNYA, ENLV, TNXP: EBITDA Margin % Comparison
For the Biotechnology subindustry, Korro Bio's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Korro Bio EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Korro Bio's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Korro Bio's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Korro Bio (KRRO) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Korro Bio and its competitors. According to the industry distribution chart, Korro Bio ranks #801 out of 945 companies in the Biotechnology industry, placing it in the top 84.8%.
Is Korro Bio's EBITDA Margin % too high?
Korro Bio's current EBITDA Margin % is 0.00%. Based on the distribution chart, Korro Bio ranks #801 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Korro Bio has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Korro Bio's EBITDA Margin % compare to TNYA and ENLV?
According to the Biotechnology industry distribution chart, Korro Bio ranks #801 out of 945 companies for EBITDA Margin %. This places Korro Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Korro Bio and its competitors. Korro Bio's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Korro Bio stock overvalued right now?
Korro Bio (KRRO) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Korro Bio's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Korro Bio (KRRO), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
6GF Score
Get the complete analysis for KRRO
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KRRO has been successfully added to your 
